T C Hardin
- Infectious Diseases top 5%
- Epidemiology top 10%
- Small Animals top 5%
- Pharmacology
- Oncology
- Co-authors
- John R. GraybillMichael G. RinaldiRichard J. FetchickRobert WoestenborghsJohn G. KuhnP. K. SharkeyJames F. DunnDavid S. Burgess
- Topics
- Antifungal resistance and susceptibility (6 papers)Antibiotics Pharmacokinetics and Efficacy (3 papers)Infectious Diseases and Mycology (2 papers)
- Journals
- Antimicrobial Agents and ChemotherapyThe Journal of UrologyClinical Pharmacology & Therapeutics
- Partner nations
- United States
In The Last Decade
T C Hardin
14 papers receiving 508 citations
Peers
Comparison fields: 5 of 83
- Infectious Diseases 334
- Epidemiology 256
- Small Animals 77
- Pharmacology 68
- Oncology 58
Countries citing papers authored by T C Hardin
This map shows the geographic impact of T C Hardin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T C Hardin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T C Hardin more than expected).
Fields of papers citing papers by T C Hardin
This network shows the impact of papers produced by T C Hardin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T C Hardin. The network helps show where T C Hardin may publish in the future.
Co-authorship network of co-authors of T C Hardin
This figure shows the co-authorship network connecting the top 25 collaborators of T C Hardin. A scholar is included among the top collaborators of T C Hardin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T C Hardin. T C Hardin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Discrepancy between in vitro and in vivo antifungal activity of albendazole. | 7 |
| 2 | 8 | |
| 3 | 4 | |
| 4 | 49 | |
| 5 | 4 | |
| 6 | 6 | |
| 7 | Cefepime. | 7 |
| 8 | 36 | |
| 9 | 2 | |
| 10 | 119 | |
| 11 | 251 | |
| 12 | 2 | |
| 13 | Rapid replacement of serum albumin in patients receiving total parenteral nutrition. | 18 |
| 14 | B-6. Pharmacokinetics of a new β-lactam antibiotic, moxalactam | 1 |
| 15 | 23 |
About T C Hardin
T C Hardin is a scholar working on Small Animals, Applied Microbiology and Biotechnology and Infectious Diseases, having authored 15 papers that have together received 537 indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (6 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Infectious Diseases and Mycology (2 papers). The work is most often cited by research in Infectious Diseases (334 citations), Microbiology (8 citations) and Small Animals (77 citations). T C Hardin has collaborated with scholars based in United States. Frequent co-authors include John R. Graybill, Michael G. Rinaldi, Richard J. Fetchick, Robert Woestenborghs, John G. Kuhn, P. K. Sharkey, James F. Dunn, David S. Burgess, Carey P. Page and Wayne H. Schwesinger. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, The Journal of Urology and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.